Research and Markets: Designing Effective Pharmaceutical Brand Teams: Structure, Governance, Performance and Operations Guide

DUBLIN--(Business Wire)--
Research and Markets
(http://www.researchandmarkets.com/research/796747/designing_effectiv) has
announced the addition of the "Designing Effective Pharmaceutical Brand Teams:
Structure, Governance, Performance and Operations" report to their offering.

Beyond a medication's clinical effectiveness, high-performing pharmaceutical or
biotech company's brand teams are the engine behind commercialization and brand
performance. This 69-slide study identifies key benchmarks and strategies for
designing effective brand teams. The research provides pharmaceutical or biotech
brand team leaders and product managers with benchmark metrics from 33 brands
against which they can compare themselves and their organizations. Rich,
qualitative insights are also included from many of these same brand team
leaders and can be used to avoid common pitfalls in brand team management and
governance.

In addition to survey-based metrics, qualitative insights from interviews were
derived in the following areas:

* Brand Team Size
* Functional Representation of Brand Team
* Brand Team Leadership
* Meeting Frequencies and Agendas
* Accountability and Responsibilities (Governance & Decision Rights)
* Brand Team Performance
* Communications and Decision-Making

KEY METRICS

Each of the topic areas above has associated metrics, including:

Brand Team Size Metrics:

* Average and Median of Core and Extended Teams
* Average Core & Extended Teams by Revenue Class
* Average Core & Extended Teams by Product Age
* Average Core & Extended Teams by Product Type (Specialty or Primary)
* Average Core and Extended Teams by Type of Brand (Co-promoted or
Regular)Meeting Frequencies and Agendas

Functional Representation of Brand Team Metrics:

* Percent of Companies with Various Functions on Core Brand Teams by Product
Type
* Percent of Companies with Various Functions on Extended Brand Teams by Product
Type
* Percent of Companies Where Function is on Core Team and/or Extended Team
* Percent of Functions Represented through a Shared Services Model

Brand Team Leadership Metrics:

* Percent of Leaders by Functional Area
* Percent of Leaders by Title/Level
* Percent of Leaders by Function to Whom they Report
* Percent of Leaders by Title to Whom they Report

Meeting Frequency and Agendas Metrics:

* Frequency of Meetings of Core and Extended Brand Teams
* Percent of Meetings with Standing Agendas

Accountability and Responsibility Metrics:

* Percent of Brand Teams Accountable and/or Responsible for Various Activities
* Percent of Brand Teams with Various Decision Review Bodies

Brand Team Performance Metrics:

* Percent of Brand Teams with Special Incentives Related to Brand Performance
* Recent Average Product Growth Rates by Brand Team Incentive Structure
* Percent of Brand Teams that Contribute to Performance Evaluations for Members
* Top Three Performance Metrics Used to Monitor Brand Performance
* Frequency of Communicating Brand Team Metrics

Communications and Decision-Making Metrics:

* Percent of Teams with Formal Process for Escalating/Resolving Conflicts
* Percent of Brand Teams Using Various Decision Tools to Forge Consensus
* Channel and Frequency for Communicating Brand Team Decisions

Companies Mentioned:

* Abbott
* Bayer Schering AG
* Cephalon
* Merial
* Inc.
* Orchid
* Alcon Laboratories
* Eli Lilly
* Amylin
* Genentech
* Baxter Healthcare
* GlaxoSmithKline
* Bayer
* Johnson & Johnson
* Biogen Idec
* Novartis
* Novo Nordisk
* Purdue Pharma
* Roche
* Schwarz Pharmaceuticals
* Shire
* Stiefel
* Takeda Pharmaceuticals
* TAP
* Wyeth Pharmaceuticals

For more information visit
http://www.researchandmarkets.com/research/796747/designing_effectiv.

Research and Markets
Laura Wood
Senior Manager
press@researchandmarkets.com
Fax from USA: 646-607-1907
Fax from rest of the world: +353-1-481-1716

Copyright Business Wire 2009